• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Eitan Medical Receives FDA Clearance for Sapphire Infusion System

    Researchers Successfully ‘Fine Tune’ New Thermoplastic Biomaterial

    RSIP Vision Announces Versatile Medical Image Segmentation Tool

    Vance Street Capital Adds Operating Partner

    Haemonetics to Acquire Cardiva for Up to $510M
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Fixing Face Mask Form and Function

    The Heart of the Matter: Trends in Cardiology

    Virtually the Same? The Challenges of Online Conferences

    Digital Health Delivers During a Year for the Ages

    Advanced Technology for Staking and Swaging Medical Plastics
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Element

    Unicep

    Medicoil

    PTI Engineered Plastics Inc.

    K-Tube Technologies
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Meeting Critical Ventilator Product Requirements Amid Pandemic

    Impact of COVID-19 on the Medtech Supply Chain

    Finding the Upside to a Challenging Year

    Preparing Your Design Controls for FDA Approval

    A 'Trial and Error' Approach to Micromolded Parts
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    MW Life Sciences

    Spectrum Plastics Group

    maxon

    PTI Engineered Plastics Inc.

    Element
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Top30

    17. Fresenius

    ...

    17. Fresenius
    Related CONTENT
    • 6. BD
    • 15. B. Braun
    • 18. 3M Health Care
    • 21. Smith & Nephew
    • 22. Dentsply Sirona
    07.30.19
    AT A GLANCE
    Rank: #17 (Last year: #16)
    $6.06 Billion (38.4B total)
    Prior Fiscal: $6.0 billion
    Percentage Change: +1%
    No. of Employees: 276,750 (total)
    Global Headquarters: Bad Homburg, Germany

    KEY EXECUTIVES
    Stephan Sturm, Chairman of the Management Board
    Francesco De Meo, CEO, Fresenius Helios
    Rachel Empey, CFO
    Jürgen Götz, Chief Legal and Compliance Officer, and Labor Relations Director
    Mats Henriksson, CEO, Fresenius Kabi
    Rice Powell, CEO, Fresenius Medical Care
    Ernst Wastler, CEO, Fresenius Vamed

    It started in August 2017 when Fresenius Medical Care—one of the four “groups” that comprise Fresenius—made a bid to purchase NxStage Medical—a manufacturer of end-stage renal disease and acute kidney failure products—for $30 per share in cash. That sparked the beginning of an almost year and a half-long venture to complete a deal that encountered delays virtually throughout the entire timeframe.

    Undoubtedly, the transaction was seen as potentially dead more than a couple times, while NxStage’s stock price fluctuated substantially and losses were being reported. The buyout, however, had received the necessary approval of shareholders and passed antitrust clearance in Germany and the U.K. On the other hand, the U.S. Federal Trade Commission (FTC) still hadn’t provided its blessing on the arrangement. An August 2018 deadline to complete the transaction was looming uncomfortably for many stakeholders involved.

    Then in July 2018, about a month before the deadline, NxStage sold its bloodlines business to B. Braun for an undisclosed amount. The sale included the Streamline Bloodline for the Dialog+ hemodialysis system, Streamline Bloodline for the Fresenius Medical Care hemodialysis system, and Streamline Bloodline Long for the Fresenius Medical Care hemodialysis system. The divestiture was performed in order to help gain FTC approval of the Fresenius buyout and was made contingent on the closure of that merger.

    More positive news soon followed that announcement and kept the prospect of a successful transaction alive. Just before the deal’s deadline was scheduled to arrive, it was pushed back 90 days to Nov. 5, providing NxStage additional time to clear up any lingering questions from the FTC. A second 90-day delay then was agreed upon just prior to the new deadline, which moved any close of the merger to the next calendar year. Fresenius Medical Care’s CEO Rice Powell explained the second delay was also done to provide even more time for the FTC review.

    “NxStage will close. We are later in the year than any of us imagined we would be, but we still believe that it will close,” Rice proclaimed to investors.

    Finally, on Feb. 22, 2019, Rice was able to make good on his promise. Just a few days after finally obtaining the FTC’s antitrust approval of the merger, Fresenius Medical Care closed its purchase or NxStage Medical that began approximately 18 months earlier, substantially increasing the home dialysis offerings for the company. According to Reuters, Fresenius is targeting 15 percent of its treatments to be performed within the home by 2022; at the end of 2018, that figure was around 12 percent.

    The influx of the new revenue stream via the NxStage acquisition will certainly be welcomed by a company that saw a decrease in sales dollars from 2017 to 2018. Fresenius, as a whole, lost approximately $350 million, or about 1 percent, between the two fiscal years, posting 33.89 billion euros in ’17 and 33.53 billion euros in ’18.

    Beneficiary of the new capabilities and product offerings tied to NxStage Medical, Fresenius Medical Care already led the conglomerate in terms of highest annual sales. Although it was down just a bit from its 2017 total of 16.74 billion euros, the business contributed a company-leading 16.55 billion euros. The unit, which focuses on products and services for people with chronic kidney failure, is divided into two segments—Health Care Services and Health Care Products. The significantly larger Services portion saw 2018 sales of 13.26 billion euros in 2018, down 2 percent from the prior year. Products, on the other hand, saw a 1 percent gain between the two years, ending up with 3.28 billion euros during the fiscal period.

    Looking at the worldwide market, the demand for the Medical Care offerings originate primarily in North America, where 2018 sales came in at 11.57 billion euros (70 percent of the group’s total sales). That figure, however, marked a 10 percent decline over 2017. Growth was observed in Europe/Middle East/Africa (EMEA) and Asia-Pacific, rising 2 percent and 4 percent respectively. EMEA ended 2018 with sales of 2.59 billion euros, while Asia-Pacific finished with 1.69 billion euros. Experiencing a 5 percent decline, Latin America closed the year with 686 million euros in sales.

    The Fresenius Kabi group is divided into four segments, two of which contribute to the annual sales total in this report’s figure. Overall, the unit saw gains across every portion with positive organic sales growth. The group, which specializes in the therapy and care of chronically and critically ill people, contributed 6.54 billion euros to Fresenius’ annual figure, reflecting 7 percent organic sales growth. IV drugs, the largest unit in Kabi, grew 5 percent organically to finish at 2.74 billion euros for 2018. Clinical Nutrition followed with 1.80 billion euros, up 13 percent in organic sales growth from 2017’s 1.67 billion euros.

    The remaining two groups join Medical Care’s Products portion to round out the total sales figure for this report. The first—Medical Devices/Transfusion Technology—witnessed 4 percent organic growth, although actual sales totals remained flat between 2018 and 2017. It finished the latest fiscal year at 1.08 billion euros. The last group in Kabi, Infusion Therapy, posted 929 million euros in sales, an organic increase of 7 percent.

    Sales totals for Kabi in North America and Europe were almost even—2.36 billion euros and 2.25 billion euros respectively. Asia-Pacific contributed 1.3 billion euros to the unit’s sales, while Latin America/Africa brought in 637 million euros.

    Serving as a leading private hospital operator in Europe, with 221 medical facilities in Germany and 404 healthcare centers in Spain, Fresenius Helios enjoyed a 4 percent overall rise in sales during fiscal 2018. The group finished the year at 8.99 billion euros. That total was split at an almost 2:1 ratio between the German and Spanish locations. Sales from the centers in Germany came in at 5.97 billion euros (a 2 percent loss over prior year), while Spain posted 3.02 billion euros (a 17 percent gain).

    The last group of the four that comprise Fresenius as a single entity is Vamed. According to the firm’s annual report, Fresenius Vamed manages projects, provides services for hospitals and other healthcare facilities worldwide, and is a leading post-acute care provider in Central Europe. Total sales for the group was 1.69 billion euros—a 37 percent increase over the previous year. Europe accounts for the overwhelming majority of that revenue (78 percent), with other regions making up the balance (Africa, 6 percent; Asia-Pacific, 13 percent; and Latin America, 3 percent). Both units within Vamed saw strong growth, but the Service business sales jumped 57 percent to end at 976 million euros. Project business grew 17 percent to end the year at 712 million euros.

    Looking to the future to ensure continued success, Fresenius made a number of investments during 2018 toward that effort. At the firm’s global headquarters, work was being conducted on a new research and development center. With the goal of bringing all R&D employees of the Medical Care segment together at one site, the new facility would connect to the company’s existing R&D center at the location.

    The company also broke ground for a new technology center in Schweinfurt, Germany, which is also intended to be used by the Medical Care group. The 86,000-square-foot facility would be used across departments in an effort to better blend production and development. 
    Related Searches
    • manufacturer
    • cfo
    • sales
    • clearance
    Suggested For You
    6. BD 6. BD
    15. B. Braun 15. B. Braun
    18. 3M Health Care 18. 3M Health Care
    21. Smith & Nephew 21. Smith & Nephew
    22. Dentsply Sirona 22. Dentsply Sirona
    27. Hologic 27. Hologic
    30. Sonova 30. Sonova
    Fresenius Recalls Infusion Pump & Software Over Anomalies, End of Infusion Alarm Fresenius Recalls Infusion Pump & Software Over Anomalies, End of Infusion Alarm
    Fist Assist Devices Announces Approval of FACT by University of Chicago Medical Center Fist Assist Devices Announces Approval of FACT by University of Chicago Medical Center
    B. Braun Medical Acquires NxStage Medical Inc.’s Streamline Bloodlines B. Braun Medical Acquires NxStage Medical Inc.’s Streamline Bloodlines
    Fresenius Medical Care Fined $231M to Settle Bribery Charges Fresenius Medical Care Fined $231M to Settle Bribery Charges
    Fresenius Completes NxStage Acquisition Fresenius Completes NxStage Acquisition
    NxStage Must Divest Bloodline Tubing Biz to B. Braun to Complete Fresenius Merger NxStage Must Divest Bloodline Tubing Biz to B. Braun to Complete Fresenius Merger
    FDA Clears Fresenius Kabi FDA Clears Fresenius Kabi's Fenwal Amicus Red Blood Cell Exchange Protocol

    Related Top30

    • The 2020 Top 30 Global Medical Device Companies

      The 2020 Top 30 Global Medical Device Companies

      Leadership changes, divestments, and portfolio-building partnerships—through acquisition or collaboration—were common threads among medtech’s largest players.
      MPO Editors 07.21.20

    • The 2019 Top 30 Global Medical Device Companies

      The 2019 Top 30 Global Medical Device Companies

      ...
      Sean Fenske, Michael Barbella, & Sam Brusco, MPO Editorial Staff 07.30.19

    • 1. Medtronic

      1. Medtronic

      ...
      07.30.19


    • 2. Johnson & Johnson

      2. Johnson & Johnson

      ...
      07.30.19

    • 3. GE Healthcare

      3. GE Healthcare

      ...
      07.30.19

    • 4. Abbott

      4. Abbott

      ...
      07.30.19


    • 5. Philips

      5. Philips

      ...
      07.30.19

    • 6. BD

      6. BD

      ...
      07.30.19

    • 7. Cardinal Health

      7. Cardinal Health

      ...
      07.30.19


    • 7. Siemens Healthineers

      7. Siemens Healthineers

      ...
      07.30.19

    • 9. Stryker

      9. Stryker

      ...
      07.30.19

    • 10. Baxter

      10. Baxter

      ...
      07.30.19


    • 11. Boston Scientific

      11. Boston Scientific

      ...
      07.30.19

    • 12. Danaher

      12. Danaher

      ...
      07.30.19

    • 13. EssilorLuxottica

      13. EssilorLuxottica

      ...
      07.30.19


    Trending
    • Telemedicine, Regulatory Changes To Characterize Medtech Industry In 2021
    • Philips Buys Capsule Technologies In $635M Deal
    • Cytotron Gains Breakthrough Status To Treat Breast, Liver, And Pancreatic Cancers
    • Top 10 Trends In The Medical Device And Equipment Industry
    • Haemonetics To Acquire Cardiva For Up To $510M
    Breaking News
    • Eitan Medical Receives FDA Clearance for Sapphire Infusion System
    • Researchers Successfully ‘Fine Tune’ New Thermoplastic Biomaterial
    • RSIP Vision Announces Versatile Medical Image Segmentation Tool
    • Vance Street Capital Adds Operating Partner
    • Haemonetics to Acquire Cardiva for Up to $510M
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Pharmaceutical Focus: A Look at Combination Products
    • The Printed World: Additive Manufacturing in Medtech
    • The Lost Year: 2020 Year in Review
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Ingredient Manufacturers Discuss the E-Sports Market
    Euromonitor Names Top Ten Trends for 2021
    Study Highlights Differences Between EPA's and DHA's Effect on Sleep
    Coatings World

    Latest Breaking News From Coatings World

    IGL Coatings Launches Graphene Reinforced Dual System Ceramic Coating
    Miller Paint Declares Simple Serenity its 2021 Color of the Year
    TAUBMANS Paint by PPG Releases ‘Chromatic Joy’ Palettes
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Eitan Medical Receives FDA Clearance for Sapphire Infusion System
    Researchers Successfully ‘Fine Tune’ New Thermoplastic Biomaterial
    RSIP Vision Announces Versatile Medical Image Segmentation Tool
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Global Biosciences Co. Selects ValGenesis VLMS
    Eisai Appoints Chief Clinical Officer of Oncology Biz
    Nexelis Acquires GSK Vax Lab in Marburg
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Top Beauty Brands in the World—And Most Loved Fragrances
    P&G Reports Q2 Results
    A Lacquering Technique Makes Very Good Girl by Carolina Herrera Shine
    Happi

    Latest Breaking News From Happi

    Flow Launches Collagen Waters
    Associations Congratulate Biden & Harris
    David Stanko Joins JPMS
    Ink World

    Latest Breaking News From Ink World

    Morancé Soudure France Adds Comexi F2 MC 10-color Flexo Press
    THIMM Group Installs 1st Koenig & Bauer CorruFLEX
    Cowan Graphics Adds Fujifilm Inca OnsetX3 HS
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Domino grows installation and service teams
    ABG keeps pace with demand with recruitment drive
    Acucote expands FSC-certified portfolio
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    First Quality Launches Incognito by Prevail
    Essity Launches Reusable Underwear Product
    Honeywell Delivered 225 Million Masks in December
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    DJO Acquires Trilliant Surgical
    FDA Breakthrough Device Designation Granted to Spiderwort's Spinal Cord Technology
    Bioventus Appoints SVP of Operations
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    UDC Subsidiary Adesis' Website Wins 2020 MarCom Platinum Award
    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Graphene Flagship Launches Redesigned Website

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login